These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Autoimmunity: effectiveness of treatments for pregnant women with APS. Gelber SE; Salmon JE Nat Rev Rheumatol; 2010 Apr; 6(4):187-9. PubMed ID: 20357787 [No Abstract] [Full Text] [Related]
6. Aspirin or heparin or both in the treatment of recurrent spontaneous abortion in women with antiphospholipid antibody syndrome: a meta-analysis of randomized controlled trials. Lu C; Liu Y; Jiang HL J Matern Fetal Neonatal Med; 2019 Apr; 32(8):1299-1311. PubMed ID: 29179589 [TBL] [Abstract][Full Text] [Related]
7. Low-molecular-weight heparin versus intravenous immunoglobulin for recurrent abortion associated with antiphospholipid antibody syndrome. Dendrinos S; Sakkas E; Makrakis E Int J Gynaecol Obstet; 2009 Mar; 104(3):223-5. PubMed ID: 19116178 [TBL] [Abstract][Full Text] [Related]
8. [Diagnosis and treatment of antiphospholipid antibody-related recurrent spontaneous abortion and analysis of therapeutic drugs and pregnancy outcome in 75 patients with antiphospholipid syndrome]. Li XY; Zhao JX; Liu XY Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Dec; 50(6):956-961. PubMed ID: 30562764 [TBL] [Abstract][Full Text] [Related]
9. Effects of unfractionated and low molecular weight heparin on antiphospholipid antibody binding in vitro. Franklin RD; Kutteh WH Obstet Gynecol; 2003 Mar; 101(3):455-62. PubMed ID: 12636948 [TBL] [Abstract][Full Text] [Related]
10. Randomized study of subcutaneous low molecular weight heparin plus aspirin versus intravenous immunoglobulin in the treatment of recurrent fetal loss associated with antiphospholipid antibodies. Triolo G; Ferrante A; Ciccia F; Accardo-Palumbo A; Perino A; Castelli A; Giarratano A; Licata G Arthritis Rheum; 2003 Mar; 48(3):728-31. PubMed ID: 12632426 [TBL] [Abstract][Full Text] [Related]
11. Low molecular weight heparin and aspirin for recurrent pregnancy loss: results from the HepASA trial. Carp HJ J Rheumatol; 2010 Jan; 37(1):202; author reply 203. PubMed ID: 20040643 [No Abstract] [Full Text] [Related]
12. Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss. Hamulyák EN; Scheres LJ; Marijnen MC; Goddijn M; Middeldorp S Cochrane Database Syst Rev; 2020 May; 5(5):CD012852. PubMed ID: 32358837 [TBL] [Abstract][Full Text] [Related]
13. Recurrent pregnancy loss with antiphospholipid antibody: a systematic review of therapeutic trials. Empson M; Lassere M; Craig JC; Scott JR Obstet Gynecol; 2002 Jan; 99(1):135-44. PubMed ID: 11777524 [TBL] [Abstract][Full Text] [Related]
14. Enoxaparin versus unfractionated heparin in the management of recurrent abortion secondary to antiphospholipid syndrome. Fouda UM; Sayed AM; Abdou AM; Ramadan DI; Fouda IM; Zaki MM Int J Gynaecol Obstet; 2011 Mar; 112(3):211-5. PubMed ID: 21251653 [TBL] [Abstract][Full Text] [Related]
15. The management of pregnant patients with antiphospholipid syndrome. Cervera R; Balasch J Lupus; 2004; 13(9):683-7. PubMed ID: 15485103 [TBL] [Abstract][Full Text] [Related]
18. Antibody profile of pregnant women with antiphospholipid syndrome and pregnancy outcome after treatment with low dose aspirin and low-weight-molecular heparin. Glasnović M; Bosnjak I; Vcev A; Soldo I; Kosuta M; Lenz B; Glasnović-Horvatić E; Soldo-Butković S; Mićunović N Coll Antropol; 2007 Mar; 31(1):173-7. PubMed ID: 17598397 [TBL] [Abstract][Full Text] [Related]
19. Combination of heparin and aspirin is superior to aspirin alone in enhancing live births in patients with recurrent pregnancy loss and positive anti-phospholipid antibodies: a meta-analysis of randomized controlled trials and meta-regression. Mak A; Cheung MW; Cheak AA; Ho RC Rheumatology (Oxford); 2010 Feb; 49(2):281-8. PubMed ID: 19965971 [TBL] [Abstract][Full Text] [Related]
20. Heparin or aspirin or both in the treatment of recurrent abortions in women with antiphospholipid antibody (syndrome). Hoppe B; Burmester GR; Dörner T Curr Opin Rheumatol; 2011 May; 23(3):299-304. PubMed ID: 21346577 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]